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Background and purpose — There are limited data on risk factors 
for avascular necrosis of the hip, but cirrhosis has been proposed 
as a risk factor. We examined the association between cirrhosis 
and incidence of total hip arthroplasty for avascular necrosis.
Methods — We used nationwide healthcare data to identify 
all Danish residents diagnosed with cirrhosis in 1994–2011, and 
matched them 1:5 by age and sex to non-cirrhotic reference indi-
viduals from the general population. We excluded people with 
a previous total hip arthroplasty, a previous hip fracture, or a 
previous diagnosis of avascular necrosis. We used stratifi ed Cox 
regression to estimate the hazard ratio (HR) for cirrhosis patients 
relative to reference individuals, adjusting for potential confound-
ers. We used the cumulative incidence function to compute 5-year 
risks.
Results — We included 25,421 cirrhosis patients and 114,052 
reference individuals. Their median age was 57 years, and 65% 
were men. 45 cirrhosis patients and 44 reference individuals 
underwent total hip arthroplasty for avascular necrosis. Cirrho-
sis patients’ HR for a total hip arthroplasty for avascular necrosis 
was 10 (95% CI: 6–17), yet their 5-year risk of avascular necrosis 
was only 0.2%. For the reference individuals, the 5-year risk was 
0.02%. 
Interpretation — Cirrhosis is a strong risk factor for avascular 
necrosis of the hip, but it is rare even in cirrhosis patients.
■
Cirrhosis is the end-stage of all chronic liver diseases. It leads 
to a profound disturbance of the systemic circulation (Vallance 
and Moncada 1991), of the immune response (Lin et al. 2007), 
and of the coagulation system (Northup and Caldwell 2013), 
but whether cirrhosis is a risk factor for joint disease has not 
been determined. Avascular necrosis (AVN) is bone necrosis 
caused by insuffi cient circulation, predominantly affecting 
bone parts with poor circulation: the femoral head and to a 
lesser extent the femoral condyles and carpal bones (Chang 
et al. 1993). The pathogenesis of AVN remains poorly under-
stood, but risk factors include tobacco smoking (Hirota et al. 
1993, Matsuo et al. 1988), corticosteroid treatment (Guo et 
al. 2014), alcoholism (Hirota et al. 1993, Matsuo et al. 1988), 
fractures (Loizou and Parker 2009), and certain other condi-
tions (Mankin 1992). Hung et al. (2011) reported that cirrhosis 
may also be a risk factor. Their study compared the risk of 
AVN in cirrhosis patients and that in an age-matched cohort 
of hospitalized patients with a high prevalence of conditions 
that predispose to AVN. They may therefore have underesti-
mated the strength of the association. AVN is clinically sig-
nifi cant because many AVN patients require total hip arthro-
plasty (THA), and both AVN and cirrhosis are associated with 
an increased risk of complications after total hip arthroplasty 
(Bergh et al. 2014, Jiang et al. 2014, Deleuran et al. 2015). 
We investigated the association between cirrhosis and AVN 
of the hip. This might help us understand the pathogenesis of 
avascular necrosis, and that is the fi rst step towards preventing 
or treating the condition without surgery.
Methods
Data sources
We performed this registry-based historical cohort study in 
Denmark, which has 5.6 million inhabitants. All Danish resi-
dents are given universal, tax-paid access to hospitals. The 
Danish National Patient Registry (NPR) is a nationwide reg-
istry that has covered admissions to non-psychiatric hospitals 
since 1977 and outpatient and emergency room visits since 
1995. The data include relevant dates and discharge diagno-
ses, coded in accordance with the International Classifi cation 
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of Diseases, 10th edition (ICD-10) from 1994 and the ICD-8 
before that (Lynge et al. 2011). The Danish Hip Arthroplasty 
Registry (DHR) is a clinical database of all primary or revi-
sion total hip arthroplasties performed in Denmark since Janu-
ary 1, 1995. The data are entered by the operating surgeon 
immediately after the procedure and include the indication for 
arthroplasty (primary osteoarthritis, fracture,  avascular necro-
sis, or other indication) (Pedersen et al. 2004). The indication 
for arthroplasty has been confi rmed by medical chart review 
and radiographs in 79 of 80 randomly selected AVN patients 
(Pedersen et al. 2004). The Danish Central Offi ce of Civil 
Registration continuously monitors the vital status of Danish 
residents, including dates of emigration or death, and it issues 
a unique personal identifi cation number to everyone at birth or 
immigration. This number enables linkage of individual-level 
data between the NPR, the DHR, and the civil registration 
system (Pedersen et al. 2006).
Cirrhosis patients and reference individuals
We identifi ed all Danish residents with a fi rst-time hospital 
discharge diagnosis of alcoholic cirrhosis (ICD-10: K70.3, 
K70.4) or unspecifi ed cirrhosis (ICD-10: K74.6) between 
1994 and 2011. Biopsy or clinical evaluation had confi rmed 
85% of diagnoses for cirrhosis in the NPR in a previous val-
idation study (Vestberg et al. 1997). We defi ned the “index 
date” as the date of the fi rst cirrhosis diagnosis. To study the 
association between cirrhosis and a total hip arthroplasty for 
AVN, we excluded cirrhosis patients if they had a previous 
diagnosis of avascular necrosis (ICD-10:  M87.0), if they had 
previously undergone total hip arthroplasty, or if they were 
diagnosed with hip fracture (ICD-8: 820.xx, 821.xx, 822.xx, 
823-xx; ICD-10: S72.0, S82.0, S82.1, S83.x) before the index 
date. We matched these cirrhosis patients 1:5 on the basis of 
age, sex, and birth date to reference individuals without cir-
rhosis from the general Danish population, using risk-set sam-
pling (Langholz and Goldstein 1996). The reference individu-
als were given the same index date as the corresponding cir-
rhosis patient. We excluded reference individuals according to 
the same criteria as cirrhosis patients; this exclusion resulted 
in a situation whereby not all cirrhosis patients were matched 
1:5. 
Confounders
The NPR holds data on potential confounders of an associa-
tion between cirrhosis and AVN. We identifi ed previous emer-
gency room visits, inpatient and outpatient hospitalizations 
for conditions predisposing to AVN (diabetes, HIV infection, 
myeloproliferative disease, hemoglobinopathy, chronic renal 
failure, gout, and solid organ transplantation), an indicator of 
smoking (chronic obstructive pulmonary disease), and indica-
tors of corticosteroid treatment (autoimmune hepatitis, rheu-
matoid arthritis, and connective tissue disease) (diagnosis 
codes are shown in Table 1). As an indicator of alcohol intake, 
we identifi ed emergency room visits and inpatient and outpa-
tient hospitalizations for alcoholism or alcohol-related disor-
ders before the index date (see Supplementary data, Table 3).
Outcomes and statistical analysis
We examined one outcome: time to total hip arthroplasty for 
AVN. We followed the cirrhosis patients and the reference 
individuals from the index date to the date of total hip arthro-
plasty for AVN, date of death, or end of follow-up (December 
31, 2011). We used stratifi ed Cox regression to estimate the 
hazard ratio (HR) of total hip arthroplasty for AVN in cirrho-
sis patients as opposed to reference individuals and adjusted 
these HRs for potential confounders. We found no violations 
of the proportional hazards assumption when we tested it 
using Schoenfeld residuals and checked it by inspecting the 
log-log plot. We used the cumulative incidence function with 
death as a competing risk to compute the 5-year risk of total 
hip arthroplasty for AVN. This analysis relies on non-infor-
mative censoring. There were 2 censoring events in our study 
cohort: end of study (on December 31, 2011) and migration. 
Both of these events are unlikely predictors of the risk of a 
total hip arthroplasty for AVN, so the censoring in our study 
cohort was non-informative. Alcohol intake is a well-known 
risk factor for AVN, and cirrhosis patients have a high preva-
lence of alcohol intake. We were concerned that the regres-
sion analysis would leave residual confounding, so we per-
formed a supplementary analysis in which we used restriction 
to minimize confounding by alcohol intake. We repeated the 
regression analysis and restricted it to cirrhosis patients with 
unspecifi ed cirrhosis (ICD-10: K74.6) who had not been hos-
pitalized for an alcohol-related disorder (see Supplementary 
data, Table 3), and the corresponding reference individuals. 
Reference individuals who had previously been hospitalized 
for an alcohol-related disorder were also left out of this analy-
sis. All statistical analyses were performed using Stata version 
12.1 and the R software package version 2.14 (R 2013).  
Results 
We included 25,421 cirrhosis patients and 114,052 reference 
individuals. Their median age was 57 years and 65% were 
male. 45 cirrhosis patients and 44 reference individuals under-
went total hip arthroplasty for AVN. Diabetes and COPD were 
the most prevalent confounders, and the majority of confound-
ers were more prevalent in cirrhosis patients than in reference 
individuals (Table 1). Cirrhosis patients’ adjusted HR for a 
total hip arthroplasty for AVN was 10 (95% CI: 6–17). Both 
cirrhosis patients’ and reference individuals’ 5-year risk of a 
total hip arthroplasty for AVN was very low, but it was mark-
edly higher in cirrhosis patients: 0.16% (95% CI: 0.12–0.23) 
vs. 0.02% (95% CI: 0.01–0.03). Cirrhosis patients’ HR for a 
total hip arthroplasty for AVN was essentially unaltered in our 
supplementary analysis, restricted to patients without alco-
holic cirrhosis (Table 2).
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We performed a nationwide cohort study and found a strong 
association between cirrhosis and total hip arthroplasty for 
avascular necrosis. This association was unaltered when we 
performed a supplementary analysis to minimize the infl uence 
of alcohol intake on our results. The absolute risks of a total 
hip arthroplasty for AVN were low, but markedly higher in 
cirrhosis patients than in reference individuals.
The main strength of this study was its population-based 
design and complete follow-up. One possible limitation was 
the validity of our data sources. NPR diagnoses for cirrhosis 
have previously been validated with biopsy or clinical evalu-
ation as the gold standard. Cirrhosis was confi rmed in 85% of 
patients with this diagnosis in the NPR (Vestberg et al. 1997), 
and the bias introduced by misclassifying individuals without 
cirrhosis as cirrhosis patients, or vice versa, would cause us 
to underestimate the true strength of the association between 
cirrhosis and AVN. The indication for hip arthroplasty in the 
DHR has been validated, showing that the positive predic-
tive value for AVN was 99% (Pedersen et al. 2004). Still, it 
is possible that orthopedic surgeons are reluctant to perform 
arthroplasties in patients with cirrhosis, who have a high risk 
of postoperative complications (Deleuran et al. 2014). How-
ever, such a bias would cause us to underestimate the risk of 
Hung et al. (2011) found an HR for AVN of 2.5 in a cohort 
of patients with cirrhosis (primarily due to viral hepatitis) rela-
tive to an age-matched cohort of hospitalized patients without 
cirrhosis. These hospitalized patients without cirrhosis had 
a high prevalence of conditions that predispose to AVN, but 
the reported associations were only adjusted for conditions 
recorded at the index hospitalization. Such incomplete record-
ing of confounders may have resulted in residual confounding, 
which would have caused Hung et al. to underestimate the true 
strength of the association. 
The mechanisms behind the association between cirrhosis 
and AVN are unclear. Cirrhosis patients suffer from coagu-
lopathy, endothelial dysfunction, and chronic infl ammation 
(Albillos et al. 2014, Iwakiri and Groszmann 2007, Søgaard 
et al. 2009). Endothelial dysfunction has been linked to gluco-
corticoid-induced AVN (Chen et al. 2013), but chronic infl am-
mation may be more important for development of AVN 
(Morse et al. 2013). Interleukin-33, a T-lymphocyte activator, 
has been linked to both cirrhosis and AVN (Marvie et al. 2010, 
Zheng et al. 2014), and cirrhosis patients’ hyperdynamic cir-
culation facilitates diffusion of proinfl ammatory cytokines and 
endotoxins throughout the body (Lee et al. 1996). Hence, even 
though the exact mechanisms remain unclear, the pathophysi-
Table 1. Prevalence of risk factors for AVN at the index date, with ICD-8 and ICD-10 codes
    Cirrhosis  Reference
 ICD-8 ICD-10 patients (%) individuals (%)
Conditions predisposing to AVN   
    Diabetes mellitus 249.xx, 250.xx E10.x–E14.x 13 4
    HIV 079.83 B20.x–B24.x 0.26 0.06
    Myeloproliferative disease 20x.xx C88.x, C90–96.x 0.71 0.33
    Hemoglobinopathy  282.xx D55.x– D59.x 0.36 0.05
    Chronic renal failure  58x.xx N18.x 1.2 0.37
    Gout 274.0x M10.x 2.1 0.49
  Solid organ transplantation Y95.xx Z94.x 0.28 0.15
Indicator of smoking    
    Chronic obstructive lung disease 490.xx–492.xx J43.x–J44.x 7.2 2.4
Indicator of corticosteroid treatment   
    Autoimmune hepatitis 573.02 K73.2, K75.4 0.90 0.02
    Rheumatoid arthritis 712.0x–712.2x M05.x 0.56 0.44
    Connective tissue disease 734.xx M3x.x 0.73 1.2
Table 2. Results of the main regression analysis and the supplementary regression analysis
  
 No. of cirrhosis No. of reference Unadjusted HR a Adjusted HR b
 patients (with AVN) individuals (with AVN)  (95% CI) (95% CI)
 
Main analysis 23,421 (45) 114,052 (44) 9.9 (5.8–17) 10 (5.8–17)
Supplementary analysis   4,977 (9)   21,851 (11) 13  (3.5–48) 12 (3.3–47)
a Unadjusted hazard ratio of THA for AVN in cirrhosis patients vs. reference individuals
b Adjusted hazard ratio of THA for AVN in cirrhosis patients vs. reference individuals, adjusted for 
  other risk factors for AVN; see Table 1.
total hip arthroplasty for AVN 
and also the strength of the asso-
ciation between cirrhosis and 
total hip arthroplasty for AVN. 
Thus, bias is unlikely to explain 
the strong association between 
cirrhosis and AVN. 
Incomplete confounder con-
trol could possibly have led 
us to overestimate the effect 
of cirrhosis on the rate of total 
arthroplasty for AVN. We were 
able to adjust for conditions 
that predispose to AVN and for 
indicators of smoking and treat-
ment with corticosteroids, but 
our use of hospital diagnoses 
to identify confounders would 
probably underestimate their 
prevalence. Our results were 
unaltered when we performed 
a supplementary analysis aimed 
at minimizing the effect of alco-
hol intake. Still, we cannot rule 
out the possibility that some of 
the association was caused by 
alcohol intake and other con-
founders, but we believe that it 
is unlikely that the strong asso-
ciation was entirely the result of 
confounding.  
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ology of cirrhosis shows a number of characteristics that have 
been associated with AVN, so a causal link between cirrhosis 
and AVN is plausible.  
In conclusion, cirrhosis is a strong risk factor for avascular 
necrosis requiring total hip arthroplasty, but avascular necrosis 
is a rare condition, even in cirrhosis patients.
Supplementary data
Table 3 is available on the Acta Orthopaedica website (www.
actaorthop.org), identifi cation number 7581.
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